|
|
Thomson Financial Business Description:
| The Group's principal activities are to develop and commercialize biomaterials, implantable medical devices, and preserve and distribute human tissues for cardiovascular and vascular transplant applications. The Group operates in two segments: Implantable Medical Devices and Preservation Services. The Implantable medical devices segment includes the sales of BioGlue and bioprosthetic devices, including stentless porcine heart valves and SynerGraft processed bovine vascular grafts. The Preservation Services segment includes the preservation of cardiac, vascular, and orthopaedic allograft tissues. The Group's products are marketed in Latin America, Europe, the Middle East, Canada, South America, Australia and Asia. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on CryoLife, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
